Gyre Therapeutics (GYRE) had the highest return between February 12, 2024 and February 26, 2024 by a small-cap US stock, returning 108.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Gyre Therapeutics (GYRE) | 2/12/2024 - 2/26/2024 | 108.75% |
GeneDx (WGS) | 2/12/2024 - 2/26/2024 | 106.87% |
Iovance Biotherapeutics (IOVA) | 2/12/2024 - 2/26/2024 | 78.49% |
Ocular Therapeutix (OCUL) | 2/12/2024 - 2/26/2024 | 70.98% |
Trevi Therapeutics (TRVI) | 2/12/2024 - 2/26/2024 | 62.28% |
Nano X Imaging (NNOX) | 2/12/2024 - 2/26/2024 | 60.98% |
Janux Therapeutics (JANX) | 2/12/2024 - 2/26/2024 | 58.12% |
Codere Online US (CDRO) | 2/12/2024 - 2/26/2024 | 58.04% |
Rezolute (RZLT) | 2/12/2024 - 2/26/2024 | 51.85% |
MediaAlpha (MAX) | 2/12/2024 - 2/26/2024 | 51.12% |
Doubledown Interactive (DDI) | 2/12/2024 - 2/26/2024 | 50.73% |
Lotus Technology Inc American Depositary Shares (LOT) | 2/12/2024 - 2/26/2024 | 50.32% |
Arcutis Biotherapeutics (ARQT) | 2/12/2024 - 2/26/2024 | 49.08% |
Bicycle Therapeutics (BCYC) | 2/12/2024 - 2/26/2024 | 48.17% |
Benitec Biopharma Ltd ADR (BNTC) | 2/12/2024 - 2/26/2024 | 47.39% |
HighPeak Energy (HPKEW) | 2/12/2024 - 2/26/2024 | 47.14% |
Maravai Lifesciences Holdings (MRVI) | 2/12/2024 - 2/26/2024 | 46.13% |
Jumia Technologies (JMIA) | 2/12/2024 - 2/26/2024 | 43.96% |
Stoke Therapeutics (STOK) | 2/12/2024 - 2/26/2024 | 42.09% |
Aspen Aerogels (ASPN) | 2/12/2024 - 2/26/2024 | 41.63% |
Butterfly Network (BFLY) | 2/12/2024 - 2/26/2024 | 40% |
Now (DNOW) | 2/12/2024 - 2/26/2024 | 38.34% |
Cango (CANG) | 2/12/2024 - 2/26/2024 | 37.82% |
Advent Technologies (ADNWW) | 2/12/2024 - 2/26/2024 | 36.95% |
ASP Isotopes Inc Common Stock (ASPI) | 2/12/2024 - 2/26/2024 | 36.45% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
